4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-N-[3-(methylsulfanyl)phenyl]benzene-1-sulfonamide

Catalog No. :
ACDMPR481
CAS No. :
338775-32-9
Molecular Formula :
C19H14ClF3N2O3S2
Molecular Weight :
474.91

IUPAC Name:4-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)oxy)-N-(3-(methylthio)phenyl)benzenesulfonamide

4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-N-[3-(methylsulfanyl)phenyl]benzene-1-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-N-[3-(methylsulfanyl)phenyl]benzene-1-sulfonamide
IUPAC Name4-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)oxy)-N-(3-(methylthio)phenyl)benzenesulfonamide
Molecular FormulaC19H14ClF3N2O3S2
Molecular Weight474.91
SMILESO=S(C1=CC=C(OC2=NC=C(C(F)(F)F)C=C2Cl)C=C1)(NC3=CC=CC(SC)=C3)=O
InChI KeyGPAUSGHZOPFEMY-UHFFFAOYSA-N
Synonym4-([3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]OXY)-N-[3-(METHYLSULFANYL)PHENYL]BENZENESULFONAMIDE;4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-N-[3-(methylsulfanyl)phenyl]benzene-1-sulfonamide;Benzenesulfonamide, 4-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]-N-[3-(methylthio)phenyl]-
CAS No.338775-32-9

Synthetic Route by SureRoute

1. ACDMPR481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDMPR481 route product structure diagram
    ACDMPR481338775-32-9
Inquiry

2. ACDMPR481 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDMPR481 route product structure diagram
    ACDMPR481338775-32-9
Inquiry

Comments (0)